comparemela.com

Latest Breaking News On - Cemm research center - Page 10 : comparemela.com

Exscientia: Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes

Study shows benefit of the first AI-supported functional precision medicine platform to guide treatment selection and improve outcomes in patients with advanced haematological cancers 54% of patients

Vienna
Wien
Austria
Miami
Florida
United-states
Zurich
Züsz
Switzerland
Osaka
Japan
American

Eco-friendly process for synthesizing organic materials developed for high-performance materials industry

Eco-friendly process for synthesizing organic materials developed for high-performance materials industry
chemeurope.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chemeurope.com Daily Mail and Mail on Sunday newspapers.

Austria
Vienna
Wien
Austrian
Miriam-unterlass
Marianne-lahnsteiner
University-of-vienna
Cemm-research-center
University-of-konstanz
Uni-konstanz
Adjunct-principal-investigator
Molecular-medicine

Researchers develop new method for sequencing single cells in an efficient manner

RNA sequencing is a powerful technology for studying cells and diseases. In particular, single-cell RNA sequencing helps uncover the heterogeneity and diversity of our body.

Austria
Vienna
Wien
Austrian
Paul-datlinger
Christoph-bock
Emily-henderson
Cemm-research-center
University-of-vienna
Molecular-medicine
Austrian-academy
Medical-university

Scientists develop new method for ultra-high-throughput RNA sequencing in single cells

RNA sequencing is a powerful technology for studying cells and diseases. Scientists from the research group of Christoph Bock, principal investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and professor at the Medical University of Vienna, developed a new method for sequencing huge numbers of single cells in an efficient manner. The study has now been published in Nature Methods.

Germany
Austria
Vienna
Wien
Austrian
Martin-senekowitsch
Daniele-barreca
Paul-datlinger
Christoph-bock
Thomas-krausgruber
Thorina-boenke
Lise-meitner

Blood test detects childhood tumors based on their epigenetic profiles

Credit: Tatjana Hirschmugl A new study exploits the characteristic epigenetic signatures of childhood tumors to detect, classify and monitor the disease. The scientists analyzed short fragments of tumor DNA that are circulating in the blood. These liquid biopsy analyses exploit the unique epigenetic landscape of bone tumors and do not depend on any genetic alterations, which are rare in childhood cancers. This approach promises to improve personalized diagnostics and, possibly, future therapies of childhood tumors such as Ewing sarcoma. The study has been published in Nature Communications. A study led by scientists from St. Anna Children s Cancer Research Institute (St. Anna CCRI) in collaboration with CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences provides an innovative method for liquid biopsy analysis of childhood tumors. This method exploits the fragmentation patterns of the small DNA fragments that tumors leak into the blood stream, whi

Germany
Norway
Austria
Vienna
Wien
France
Austrian
Marie-bernkopf
Sabine-taschner-mandl
Perrine-marec
Didier-surdez
Bernadette-brennan

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.